NASDAQ:ANGI
Angie Stock News
$2.02
-0.0300 (-1.46%)
At Close: Apr 19, 2024
Angi: 10 Reasons To Be Hopeful
08:57pm, Tuesday, 20'th Dec 2022
Angi shares have been decimated, falling 80% year-to-date as key operational metrics (number of service providers, service request completions) have come in below expectations. While results have been
Goldman Sachs Has 5 Sizzling Well Known Buy Rated Stocks Under $10 With Huge Upside Potential
07:04am, Saturday, 26'th Nov 2022
While Most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the amount of shares they can buy.
Angi Inc. (ANGI) Q3 2022 Results - Earnings Call Transcript
11:18am, Wednesday, 09'th Nov 2022
Angi Inc. (NASDAQ:ANGI ) Q3 2022 Results Earnings Conference Call November 9, 2022 8:30 AM ET Company Participants Christopher Halpin - Executive Vice President and Chief Financial Officer, IAC Inc. J
Angi (ANGI) Reports Q3 Loss, Misses Revenue Estimates
06:48pm, Tuesday, 08'th Nov 2022
Angi (ANGI) delivered earnings and revenue surprises of 0% and 1.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Goldman Sachs Has 5 Stocks to Buy Under $10 With 100% to 800% Upside Potential
05:50am, Saturday, 29'th Oct 2022
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Angi Benefits From Demand Side Economics, Can Afford Widening Losses
11:47am, Thursday, 27'th Oct 2022
Angi, once Angie's List, is a directory where consumers can find home service professionals like remodelers and cleaners to work on their homes. The company benefits substantially from demand side eco
Angi (ANGI) Upgraded to Strong Buy: Here's What You Should Know
01:33pm, Friday, 14'th Oct 2022
Angi (ANGI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
IAC Shares Slide as Angi Struggles and Ad Sales Slump
05:26pm, Wednesday, 12'th Oct 2022
The sharp decline in IAC shares this year has made the stock a good buy, some analysts say.
IAC TO ANNOUNCE Q3 2022 EARNINGS ON NOVEMBER 8th AND HOST EARNINGS CONFERENCE CALL ON NOVEMBER 9th
04:10pm, Wednesday, 12'th Oct 2022
NEW YORK , Oct. 12, 2022 /PRNewswire/ -- After the close of market trading on Tuesday, November 8, 2022, IAC (NASDAQ: IAC) will post its third quarter results and simultaneously IAC CEO Joey Levin wi
Why Angi Stock Slumped This Week
08:29am, Friday, 12'th Aug 2022
The company reported concerning trends for its business during the first month of the third quarter.
Angi Inc. (ANGI) CEO Oisin Hanrahan on Q2 2022 Results - Earnings Call Transcript
02:37pm, Wednesday, 10'th Aug 2022
Angi Inc. (NASDAQ:ANGI ) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Mark Schneider - Head, Investor Relations Christopher Halpin - Chief Financial Officer, IAC Jo
Why Angi Stock Was Falling Today
12:12pm, Wednesday, 10'th Aug 2022
Second-quarter numbers were strong, but the forecast was murkier than investors wanted to hear.
Angi (ANGI) Reports Q2 Loss, Tops Revenue Estimates
07:33pm, Tuesday, 09'th Aug 2022
Angi (ANGI) delivered earnings and revenue surprises of 16.67% and 3.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks to Buy Every Investor Knows That Trade Below $10 and Have Huge Upside Potential
06:10am, Saturday, 06'th Aug 2022
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
09:20am, Friday, 15'th Jul 2022 Benzinga
Gainers
Clene Inc. (NASDAQ: CLNN) shares jumped 43.4% to close at $4.13. Clene reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8